The pre-seed round was funded by Keio Innovation Initiative, Inc. and backed CLOVERNA’s first raise. CLOVERNA is a revolutionary RNA target drug discovery technology to accelerate the rare disease treatment

Continue readingJapanese Bio StartUp CLOVERNA announces a pre-seed round by VC in Tokyo